Splicing factor SC35 regulates the alternative splicing of tau exon 10
Wei Qian,Hongwei Liang,Jianhua Shi,Jianlan Gu,Xiaolin Wu,Shibao Wang,Cheng-Xin Gong,Fei Liu
DOI: https://doi.org/10.1016/j.jalz.2010.05.905
2010-01-01
Abstract:Abnormal alternative splicing of tau exon 10 results in imbalance of 3R-tau and 4R-tau expression, which is sufficient to cause neurofibrillary degeneration. Splicing factor SC35, a member of the superfamily of the serine/arginine-rich (SR) proteins, promotes tau exon 10 inclusion. The function of SC35 is tightly regulated by phosphorylation. Recently, we have found that 3R-tau and 4R-tau is imbalanced and Dyrk1A (dual-specificity tyrosine-phosphorylated and regulated kinase 1A) phosphorylates splicing factor SF2/ASF and suppresses its role of promotion of tau exon 10 inclusion. Overexpression of Dyrk1A due to trisome in Down syndrome brain may contribute to the dysregulation of tau exon 10 splicing. By mutation of SC35 and mini-tau gene, pCI/SI9-SI10 which consists of exons 9, 10, 11, a part of intron 9 and intron 10 and RNA-chromatin immunoprecipitation (RNA-CHIP), we elucidated the molecular mechanism by which SC35 works on tau exon 10 splicing and whether and how Dyrk1A regulates SC35-promoted tau exon 10 inclusion in vitro and in cultured cells. We observed that tau pre-mRNA could be precipitated by anti-SC35 antibody. Mutation of the SC35-like exonic splicing enhancer located at exon 10 of tau affected both the binding of SC35 to tau pre-mRNA and promotion of tau exon 10 inclusion, suggesting that SC35 acts on the SC35-like exonic splicing enhancer to promote tau exon 10 inclusion. By deletion mutation, we found that RS domain of SC35 is required for the promotion of tau exon 10 inclusion. Dyrk1A phosphorylated SC35 in vitro and interacted with it in cultured cells. Overexpression of Dyrk1A affected the interaction between SC35 and tau pre-mRNA and suppressed SC35-promoted tau exon 10 inclusion. Upregulation of Dyrk1A in Down syndrome brain may cause dysregulation of tau exon 10 splicing through SF2/ASF, SC35, and other splicing factors, leading to the imbalance in 3R-tau and 4R-tau expression, which may initiate or accelerate tau pathology and cause neurofibrillary degeneration in DS brain.
What problem does this paper attempt to address?